GT199700123A - Sales dimesilato de los ligandos del neuropeptido y. - Google Patents

Sales dimesilato de los ligandos del neuropeptido y.

Info

Publication number
GT199700123A
GT199700123A GT199700123A GT199700123A GT199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A GT 199700123 A GT199700123 A GT 199700123A
Authority
GT
Guatemala
Prior art keywords
compound
neuropeptide
ligands
dimesylate
salts
Prior art date
Application number
GT199700123A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199700123A publication Critical patent/GT199700123A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GT199700123A 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y. GT199700123A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
GT199700123A true GT199700123A (es) 1999-05-19

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199700123A GT199700123A (es) 1996-11-26 1997-11-25 Sales dimesilato de los ligandos del neuropeptido y.

Country Status (23)

Country Link
US (1) US5914329A (https=)
EP (1) EP0944611B1 (https=)
JP (1) JP3120861B2 (https=)
AP (1) AP9701148A0 (https=)
AR (1) AR010304A1 (https=)
AT (1) ATE257472T1 (https=)
AU (1) AU4792497A (https=)
BR (1) BR9713538A (https=)
CA (1) CA2272927C (https=)
DE (1) DE69727155T2 (https=)
DK (1) DK0944611T3 (https=)
ES (1) ES2213207T3 (https=)
GT (1) GT199700123A (https=)
HN (1) HN1997000154A (https=)
HR (1) HRP970640A2 (https=)
ID (1) ID18964A (https=)
MA (1) MA26450A1 (https=)
PA (1) PA8441701A1 (https=)
PE (1) PE17099A1 (https=)
PT (1) PT944611E (https=)
TN (1) TNSN97191A1 (https=)
WO (1) WO1998023603A1 (https=)
ZA (1) ZA9710587B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053864A1 (en) * 2000-01-20 2004-03-18 Gerard Karsenty Methods and compositions for control of bone formation via modulation of neuropeptide y activity
CN1630514A (zh) 2001-12-05 2005-06-22 贝勒医学院 通过调节交感神经紧张性控制骨形成的方法和组合物
AU2003201055B2 (en) 2002-01-09 2007-11-29 Arexis Ab Detection of mutations
RU2361867C2 (ru) * 2004-11-23 2009-07-20 Донг Вха Фармасьютикал. Инд. Ко., Лтд. Диметансульфонат n-гидрокси-4{5-[4-(5-изопропил-2-метил-1, 3-тиазол-4-ил)фенокси]пентокси}бензамидина
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692977B2 (en) * 1994-11-07 1998-06-18 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligands

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
HRP970640A2 (en) 1998-10-31
WO1998023603A1 (en) 1998-06-04
CA2272927C (en) 2003-02-04
PT944611E (pt) 2004-04-30
US5914329A (en) 1999-06-22
ZA9710587B (en) 1999-05-25
DE69727155D1 (de) 2004-02-12
ES2213207T3 (es) 2004-08-16
HN1997000154A (es) 1999-02-09
JP2000505110A (ja) 2000-04-25
PE17099A1 (es) 1999-02-19
DK0944611T3 (da) 2004-04-13
AR010304A1 (es) 2000-06-07
ATE257472T1 (de) 2004-01-15
PA8441701A1 (es) 2000-05-24
DE69727155T2 (de) 2004-07-08
AU4792497A (en) 1998-06-22
AP9701148A0 (en) 1998-01-31
TNSN97191A1 (fr) 2005-03-15
ID18964A (id) 1998-05-28
MA26450A1 (fr) 2004-12-20
BR9713538A (https=) 2000-03-21
EP0944611A1 (en) 1999-09-29
EP0944611B1 (en) 2004-01-07
CA2272927A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
HN1997000079A (es) Analogos de indazol sustituido.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
ES2162198T3 (es) Agentes estrogenos.
HN1999000149A (es) Derivados de 4,4-biarilpiperidina
EA200000251A1 (ru) Производные резорцинола
ES2178676T3 (es) Compuestos de pirimidina substituidos y su empleo.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
HN1998000175A (es) Imidazotriazininas
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
ES2113767T3 (es) Compuestos de tipo ceramidas, su procedimiento de preparacion y su utilizacion en cosmetica o en dermatologia.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
HN1998000166A (es) Compuesto de benceno sustituido procedimiento para su preparacion y composiciones herbicidas y defoliantes que los contienen.
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
BR9811948A (pt) Secretores de hormÈnio do crescimento
MX9304524A (es) Nuevos derivados de indol y composiciones que los contienen.
HN1997000098A (es) Ccompuesto de indol 2, 3 sustituido como agentes antiinflamatorios y analgesicos.
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.
BR0316645A (pt) Derivados de isoindol
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
GT199700123A (es) Sales dimesilato de los ligandos del neuropeptido y.
MX9301112A (es) Derivados de indol.
MX9300412A (es) Derivados de 1h-bencimidazol sustituidos con pirroloimidazolilo e imadazopiridinilo
ES2169101T3 (es) Compuesto de metaloceno.